ASK REDCHAT ANYTHING ABOUT CURIS INC.
Curis Inc. (NASDAQ: CRIS)
Listen to this Section
$0.48
-0.0230
(
-4.60% )
137.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Erivedge (vismodegib)DetailsBCC (Basal Cell Carcinoma) |
Approved |
| CA-4948 (emavusertib)+/- ibrutinibDetailsNon-Hodgkin lymphoma, Blood cancer, Cancer |
Phase 1/2 |
| CA-4948 (emavusertib)DetailsAcute myeloid leukemia, Myelodysplastic syndrome, Cancer, Blood cancer |
Phase 1/2 |
| CA-4948 (emavusertib) + PembrolizumabDetailsMelanoma |
Phase 1/2 |
| CI-8993 (anti-VISTA antibody)DetailsSolid tumor/s, Cancer |
Phase 1 |
| CA-4948 (emavusertib)DetailsAcute myeloid leukemia, Myelodysplastic syndrome, Blood cancer, Cancer |
Phase 1/2 |
| CA-4948 (emavusertib)+/- ibrutinibDetailsBlood cancer, Cancer, primary central nervous system lymphomas |
Phase 1/2 |
Market Data
|
| Open |
$0.48 |
| Previous Close |
$0.50 |
| Volume |
137.9K |
| Market Cap |
$19.49M |
| Day Range |
$0.47 - $0.51 |
| 52 Week Range |
$0.46 - $3.13 |
| Shares Outstanding |
38.98M |
| Change % |
-4.60% |
| Net Change |
▼ -0.0230 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2000 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-200,950.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-05-23 |
Sale |
-4250.00 |
GREENACRE MARTYN D |
| 2024-05-23 |
Sale |
-4250.00 |
Hohneker John |
| 2024-05-23 |
Sale |
-4250.00 |
Borgman Anne Elizabeth |
| 2024-05-23 |
Sale |
-4250.00 |
Rubin Marc |
| 2024-05-23 |
Sale |
-4250.00 |
KAITIN KENNETH I |
| 2024-05-23 |
Sale |
-40700.00 |
Zung Jonathan B. |
| 2024-05-23 |
Sale |
-100000.00 |
Dentzer James E |
| 2024-05-23 |
Sale |
-39000.00 |
Duvall Diantha |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 8-k/a |
8K-related |
13 |
Nov 13, 2025 |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| 10-q |
Quarterly Reports |
63 |
Nov 06, 2025 |
| 8-k |
8K-related |
12 |
Oct 24, 2025 |
| 8-k |
8K-related |
12 |
Aug 22, 2025 |
| 8-k |
8K-related |
15 |
Aug 08, 2025 |
| 8-k |
8K-related |
14 |
Aug 05, 2025 |
| 10-q |
Quarterly Reports |
64 |
Aug 05, 2025 |
| 8-k |
8K-related |
53 |
Jul 02, 2025 |